AZD6244 had significant efficacy in BRAF PTEN mice, although in BRAF P53, despite short-term suppression of tumor growth, rapid regrowth suggested either intrinsic resistance, or the ability to rapidly reactivate suppressed signaling pathways (Fig. 2A and B). This evidence concerns the gene PTEN and neoplasm.